In this cohort study, a novel prognostic model was developed to estimate prostate cancer-specific mortality (PCSM) while ...
A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret ...
4don MSN
Easy-to-use tool can identify high- and low-risk metastatic prostate cancer patients earlier
A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment ...
TOKYO, Dec. 05, 2025 (GLOBE NEWSWIRE) -- A.D.A.M. Innovations Co. (Japanese Name: Genesis Healthcare Co.) (“A.D.A.M. Innovations” or the “Company”), Japan’s leading AI-driven genomics company, today ...
MIT and Microsoft researchers developed an AI model that designs peptide-based molecular sensors to detect cancer-linked ...
An innovative biotech startup founded by researchers at Washington University School of Medicine in St. Louis has been acquired by Lunit, a leading company in developing AI-based technologies for ...
Neoantigens are unique markers that distinguish only cancer cells. By adding B cell reactivity, cancer vaccines can move ...
The discovery could pave the way for new treatments, improved risk prediction, and earlier intervention for brain metastases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback